Clean, Private and Secure Environments for Laboratories Enhanced with Secondary Glazing

PsiOxus Therapeutics Ltd is a UK and US based cancer therapeutics company listed 25th in the Sunday Times Hiscox Tech Track 100 in 2017 for its ‘Gene Therapy for Cancer’ platform technology for the treatment of solid tumours. PsiOxus has expanded into 21,000 sq ft of new facilities including a state of the art research and development laboratory in The Quadrant at the Abingdon Science Park. .

The main contractor, Morgan Lovell specified Selectaglaze, to improve the thermal insulation and security of the building. PsiOxus’ research and development environment demands the utmost cleanliness so a glazing solution was needed to meet these requirements. As part of the refurbishment, windows with fire ratings separating the labs and corridors were also required to conform to building regulations.

Selectaglaze met the brief by installing 15 horizontal slider units with 6mm toughened low- E glass in the 2 and 3 pane options to all primary windows. The inverted u-channel section was included to sit in the bottom of each frame to minimise the dust traps and enhance the ease of cleaning. All of the secondary glazing on the ground floor was fitted with Satinovo obscurity glass.

22 Series 40 fixed light units were fitted as viewing panels in the research and development laboratories. The vision panels within the internal walls were fitted in 6mm toughened glass and in the lab areas, units were fitted with a 10mm Pyrodur glass, providing 30 minutes of fire integrity.

Share this article

Login to post comments

About us

Future Constructor & Architect is a specification platform for architects and building contractors, which focuses on top-end domestic and commercial developments.

As well as timely industry comment and legislation updates, the magazine covers recent projects and reviews the latest sustainable building products on the market. Subscribe here.

Privacy policy

Latest updates


Sign up below to receive monthly construction, architecture and product updates from FC&A via email: